
Clobetasol propionate NEW
Price | $32 | $64 |
Package | 100mg | 500mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2025-04-30 |
Product Details
Product Name: Clobetasol propionate | CAS No.: 25122-46-7 |
Purity: 99.41% | Supply Ability: 10g |
Release date: 2025/04/30 |
Product Introduction
Bioactivity
Name | Clobetasol propionate |
Description | Clobetasol propionate (CGP9555) exerts its effect by binding to cytoplasmic glucocorticoid receptors and subsequently activates glucocorticoid receptor-mediated gene expression. This results in the synthesis of certain anti-inflammatory proteins while inhibiting the synthesis of certain inflammatory mediators. Clobetasol Propionate is the propionate salt form of clobetasol, a topical synthetic corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. Specifically, clobetasol propionate appears to induce phospholipase A2 inhibitory proteins, thereby controlling the release of the inflammatory precursor arachidonic acid from membrane phospholipids by phospholipase A2. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | H2O : < 1 mg/mL (insoluble or slightly soluble) DMSO : 86 mg/mL (184.17 mM), Sonication is recommended. Ethanol : 16 mg/mL (34.26 mM), Sonication is recommended. |
Keywords | psoriasis | Inhibitor | inhibit | GlucocorticoidReceptor | Glucocorticoid Receptor | dermatoses | Cytochrome P450 | CYPs | corticosteroid | Clobetasol propionate | Clobetasol Propionate | Clobetasol | CGP-9555 | CGP 9555 |
Inhibitors Related | Tebuconazole | Hydrocortisone | Mifepristone | Apigenin | Fenofibrate | Dexamethasone acetate | Dexamethasone | Naringin | Naringenin | Tauroursodeoxycholate | Prednisone acetate | Corticosterone |
Related Compound Libraries | Bioactive Compound Library | Approved Drug Library | Drug Repurposing Compound Library | CNS-Penetrant Compound Library | Inhibitor Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Human Metabolite Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$/ |
VIP5Y
|
RongNa Biotechnology Co.,Ltd
|
2025-04-29 | |
$0.00/10g |
VIP4Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2025-04-27 | |
$0.00/1kg |
VIP1Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2025-04-25 | |
$0.00/1kg |
VIP1Y
|
Hebei Junhua Import and Export Co., LTD
|
2025-04-02 | |
$150.00/1kg |
VIP1Y
|
Hebei Zhuanglai Chemical Trading Co Ltd
|
2024-11-25 | |
$0.00/1KG |
VIP3Y
|
Hebei Chuanghai Biotechnology Co., Ltd
|
2024-11-01 | |
$1.00/1kg |
VIP7Y
|
Hebei Chuanghai Biotechnology Co., Ltd
|
2024-10-25 | |
$0.00/1g |
VIP1Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-09-06 | |
$1.90/1KG |
VIP4Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-21 | |
$0.00/1kg |
VIP2Y
|
Shaanxi TNJONE Pharmaceutical Co., Ltd
|
2024-04-22 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY